Kite Lake Capital Management (UK)’s Pacific Biosciences PACB Stock Holding History

Kite Lake Capital Management (UK)’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-658,092	Closed	-$6.5M	–	8
2020 Q3	$6.5M	Sell	658,092 -3,340,002	-84%	-$19.2M	6.5%	4
2020 Q2	$13.8M	Sell	3,998,094 -1,492,900	-27%	-$5.08M	21.46%	2
2020 Q1	$16.8M	Buy	+5,490,994	New	+$22.5M	26.82%	2
2019 Q4	–	Sell	-3,689,527	Closed	-$19M	–	4
2019 Q3	$19M	Buy	3,689,527 +186,234	+5%	+$1.04M	10.11%	4
2019 Q2	$21.2M	Buy	3,503,293 +923,272	+36%	+$6.47M	6.13%	5
2019 Q1	$18.7M	Buy	+2,580,021	New	+$18.7M	5.34%	7

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Kite Lake Capital Management (UK)'s PACB Position: Q4 2020 in Review

Kite Lake Capital Management (UK) sold out of Pacific Biosciences (PACB) in Q4 2020, closing a stake of 658,092 shares — an estimated $6.5M sold.

Kite Lake Capital Management (UK) first reported a position in PACB in Q1 2019 and held it in 6 quarters. The position peaked at $21.2M in Q2 2019. 210 funds tracked by Wall St. Rank hold PACB as of Q4 2020.

Kite Lake Capital Management (UK) reported no remaining Pacific Biosciences position as of Q4 2020 after selling out during the quarter.
Kite Lake Capital Management (UK) sold 658,092 Pacific Biosciences shares in Q4 2020, an estimated $6.5M.
Kite Lake Capital Management (UK) first reported a position in Pacific Biosciences in Q1 2019 and held it in 6 quarters.
Kite Lake Capital Management (UK)'s Pacific Biosciences position peaked at $21.2M in Q2 2019.
210 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2020.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q4 2020, filed 16 Feb 2021.